Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer]

[Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer] Abstract Text:

    meng-hua daiMeng-hua Dai,yu-pei zhaoYu-pei Zhao,li-xing caiLi-xing Cai,yu zhuYu Zhu,

    OBJECTIVE: To confirm the effect of combined detection of K-ras gene mutation and CA19-9 level in plasma in the diagnosis of pancreatic carcinoma. METHODS: In 33 patients without pancreatic carcinoma and 15 patients with pancreatic carcinoma, the value of K-ras mutation and CA19-9 level were examined by enriched polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) and radioimmunoassay respectively. The data were analysed with chi(2) test, Fisher's exact test and Kruekal-wall's test. All patients were confirmed pathologically. RESULTS: Eleven of the 15 patients with pancreatic carcinoma and 2 of 10 patients with chronic pancreatitis were found K-ras mutation. CA19-9 level in patients with pancreatic cancer was significantly higher than that in those with benign disease but with a low specificity. The sensitivity, specificity of combined detection of K-ras gene mutation and CA19-9 level in the plasma of patients with pancreatic cancer were 66.67% and 97%. There was a significant difference between patients with pancreatic cancer and those without pancreatic cancer. Pathological examination showed atypical hyperplasia in one patient with chronic pancreatitis who had K-ras mutation and higher CA19-9 level. CONCLUSIONS: Combined detection of K-ras gene mutation and CA19-9 can be used for adjuvant diagnosis of pancreatic cancer. It is more specific than detection of single K-ras gene mutation or CA19-9 level in the plasma. The method is complementary to single detection of K-ras gene mutation or CA19-9 level because it decreases the rate of false-positive diagnosis.

    [Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer] Publishing Authors By Initials

    mh daiMH Dai,yp zhaoYP Zhao,lx caiLX Cai,y zhuY Zhu,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Zhonghua wai ke za zhi [Chinese journal of surgery

    VOLUME: 41

    Page Numbers: 332-5

    Journal Abbreviation: Zhonghua Wai Ke Za Zhi

    ISSN: 0529-5815

    DAY: 1

    MONTH: May

    YEAR: 2003

    [Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer] Information

    Number of References:

    LANGUAGE: chi

    NlmUniqueID: 153611

    [Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer]

    AFFILIATION: Department of General Surgery. Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Zhonghua Wai Ke Za Zhi

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Combined detection of K-ras mutation and CA19-9 level in plasma of patients with pancreatic cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News